Jan 9 (Reuters) - I‘rom Group Co Ltd
* Says co’s wholly owned unit ID Pharma signs iPS cell (induced pluripotent stem cell) technology related license agreement with U.S.-based firm Q-State Biosciences Inc
Source text in Japanese: goo.gl/xfg8so
Further company coverage: (Beijing Headline News)
 